A case of a novel mutant vasopressin receptor-dependent nephrogenic diabetes insipidus with bilateral non-obstructive hydronephrosis in a middle aged man - Differentiation from aquaporin-dependent nephrogenic diabetes insipidus by the response of factor VIII and von Willebrand factor to 1-deamino-8-D-arginine vasopressin administration

被引:8
作者
Miyakoshi, M
Kamoi, K
Uchida, S
Sasaki, S
机构
[1] Nagaoka Red Cross Hosp, Dept Internal Med, Div Endocrine & Metab, Nagaoka, Niigata 9402085, Japan
[2] Tokyo Med & Dent Univ, Dept Homeostasis Med & Nephrol, Tokyo 1138519, Japan
关键词
AVPR gene; nephrogenic diabetes insipidus; DDAVP; factor VIII and von Willebrand factor (vWF);
D O I
10.1507/endocrj.50.809
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
We describe a case of a novel mutant vasopressin 2 receptor (V2R)-dependent nephrogenic diabetes insipidus (NDI) with bilateral non-obstructive hydronephrosis in a middle aged man. This could be distinguished from aquaporin 2 (AQP2)-dependent NDI by the response of factor VIII and von Willebrand factor (vWF) to 1-deamino-8-D-arginine vasopressin (DDAVP) administration. A 47-year-old man was admitted to hospital because of polyuria, which had been present from infancy and was suspected of causing non-obstructive hydronephrosis. His mother's father, the older brother of his mother and his second daughter also all had polyuria. Sodium concentration, osmolality and vasopressin in blood were high, while sodium concentration and osmolality in urine were low. There were no changes in urine osmolality, factor VIII and vWF in response to DDAVP infusion. Neither was heart rate, diastolic blood pressure nor facial flushing affected. These findings suggested this case was V2R-dependent NDI rather than AQP2-dependent NDI. Molecular genetic analysis demonstrated that the patient had a V2R missense mutation involving a substitution of cysteine for arginine at position 104 (R104C) located in the first extracellular loop of the V2R. It was also found that the patient's mother and his second daughter were heterozygous for this R104C mutation.
引用
收藏
页码:809 / 814
页数:6
相关论文
共 18 条
[1]
EPINEPHRINE AND DDAVP ADMINISTRATION IN PATIENTS WITH CONGENITAL NEPHROGENIC DIABETES-INSIPIDUS - EVIDENCE FOR A PRE-CYCLIC AMP V2-RECEPTOR DEFECTIVE MECHANISM [J].
BICHET, DG ;
RAZI, M ;
ARTHUS, MF ;
LONERGAN, M ;
TITTLEY, P ;
SMILEY, RK ;
ROCK, G ;
HIRSCH, DJ .
KIDNEY INTERNATIONAL, 1989, 36 (05) :859-866
[2]
X-LINKED NEPHROGENIC DIABETES-INSIPIDUS MUTATIONS IN NORTH-AMERICA AND THE HOPEWELL HYPOTHESIS [J].
BICHET, DG ;
ARTHUS, MF ;
LONERGAN, M ;
HENDY, GN ;
PARADIS, AJ ;
FUJIWARA, TM ;
MORGAN, K ;
GREGORY, MC ;
ROSENTHAL, W ;
DIDWANIA, A ;
ANTARAMIAN, A ;
BIRNBAUMER, M .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (03) :1262-1268
[3]
HEMODYNAMIC AND COAGULATION RESPONSES TO 1-DESAMINO[8-D-ARGININE] VASOPRESSIN IN PATIENTS WITH CONGENITAL NEPHROGENIC DIABETES-INSIPIDUS [J].
BICHET, DG ;
RAZI, M ;
LONERGAN, M ;
ARTHUS, MF ;
PAPUKNA, V ;
KORTAS, C ;
BARJON, JN .
NEW ENGLAND JOURNAL OF MEDICINE, 1988, 318 (14) :881-887
[4]
BRINK HS, 1993, NETH J MED, V43, P5
[5]
Deen PMT, 1996, J AM SOC NEPHROL, V7, P836
[6]
Evrard A, 1999, ANN ENDOCRINOL-PARIS, V60, P457
[7]
NORMAL HEMODYNAMIC AND COAGULATION RESPONSES TO 1-DEAMINO-8-D-ARGININE VASOPRESSIN IN A CASE OF LITHIUM-INDUCED NEPHROGENIC DIABETES-INSIPIDUS - RESULTS OF TREATMENT BY A PROSTAGLANDIN SYNTHESIS INHIBITOR (INDOMETHACIN) [J].
HOBER, C ;
VANTYGHEM, MC ;
RACADOT, A ;
CAPPOEN, JP ;
LEFEBVRE, J .
HORMONE RESEARCH, 1992, 37 (4-5) :190-195
[8]
Autosomal recessive nephrogenic diabetes insipidus caused by an Aquaporin-2 mutation [J].
Hochberg, Z ;
VanLieburg, A ;
Even, L ;
Brenner, B ;
Lanir, N ;
VanOost, BA ;
Knoers, NVAM .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (02) :686-689
[9]
The property of a novel V2 receptor mutant in a patient with nephrogenic diabetes insipidus [J].
Inaba, S ;
Hatakeyama, H ;
Taniguchi, N ;
Miyamori, I .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (01) :381-385
[10]
Krawczak M, 2000, HUM MUTAT, V15, P45, DOI 10.1002/(SICI)1098-1004(200001)15:1<45::AID-HUMU10>3.0.CO